Related Experiment Video
Updated: May 3, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Cognitive profile of CADASIL patients with R544C Notch3 mutation
Jung-Kook Song1, Young Ook Noh, Jung Seok Lee
1Preventive Medicine, Jeju National University College of Medicine, Jeju, South Korea.
Insights
Patients with Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) carrying the R544C mutation show cognitive deficits, particularly in attention and executive function. These impairments are linked to brain imaging findings like lacunes.
Area of Science:
- Neurology
- Genetics
- Neuroimaging
Background:
- Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is a genetic microangiopathy linked to Notch3 gene mutations.
- The R544C mutation is a specific genetic variant within the Notch3 gene associated with CADASIL.
Purpose of the Study:
- To investigate the cognitive and neuroimaging characteristics of CADASIL patients with the R544C mutation.
- To compare cognitive function between CADASIL patients with and without dementia, and with healthy controls.
Main Methods:
- Neuropsychological testing was administered to 58 CADASIL R544C patients and 26 controls.
- Patients were categorized into CADASIL with dementia (CADASIL-D) and CADASIL no dementia (CADASIL-ND) groups.
- Brain MRI was performed on R544C patients; linear regression analyzed the impact of lacunes and white matter hyperintensities on cognition in the CADASIL-ND group.
Main Results:
- The CADASIL-ND group showed significant deficits in attention, executive function, and motor control compared to controls.
- The CADASIL-D group exhibited impairments across most cognitive domains, excluding language.
- In the CADASIL-ND group, increased lacunes correlated with lower scores on the Alzheimer's Disease Assessment Scale cognitive subtest and Stroop color test.
Conclusions:
- CADASIL patients with the R544C mutation exhibit distinct patterns of cognitive impairment.
- The study highlights the association between specific neuroimaging markers (lacunes) and cognitive decline in non-demented CADASIL patients.
- Cognitive impairment patterns in R544C CADASIL patients appear consistent across different ethnicities.
Background:
Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an inherited microangiopathy caused by mutations in the Notch3 gene. In the present study, we aimed to analyze cognitive and neuroimaging profiles of CADASIL patients with R544C mutation.
Methods:
Fifty-eight consecutive patients with R544C mutation and 26 normal controls were investigated. The patients were divided into two groups depending on the presence (CADASIL with dementia: CADASIL-D) or absence of dementia (CADASIL no dementia: CADASIL-ND). We applied the same neuropsychological test to the three groups. Brain magnetic resonance images were obtained from 58 patients with R544C mutation. Linear regression models were used to assess the impact of lacunes and white matter hyperintensities on cognitive function in the CADASIL-ND group.
Results:
Compared to controls, the CADASIL-ND group demonstrated significant difficulties concerning measures of attention, executive function, and motor control. The CADASIL-D group was impaired in all cognitive domains that were assessed, except the language domain. After correction for age and educational level, the number of lacunes was associated with lower scores in the Alzheimer's Disease Assessment Scale cognitive subtest and Stroop color test in the CADASIL-ND group.
Conclusions:
Non-Caucasian CADASIL patients with R544C mutation and Caucasian CADASIL patients show similar patterns of cognitive impairment.
More Related Videos
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017